The Impact of Weight Loss Programs on BMI Trajectory in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Veterans Health Administration Study.
Am J Gastroenterol
; 2024 Mar 27.
Article
in En
| MEDLINE
| ID: mdl-38534167
ABSTRACT
BACKGROUND:
Weight loss is the mainstay of management for patients with metabolic dysfunction-associated steatotic liver disease. We studied the impact of referral to MOVE!, a nationally-implemented behavioral weight loss program, on weight in MASLD patients.METHODS:
This retrospective cohort study included 102,294 MASLD patients from 125 Veterans Health Administration centers from 2008-2022.RESULTS:
Most patients lost no significant weight or gained weight. Increased engagement with MOVE! was associated with greater hazard of significant weight loss compared to no engagement.CONCLUSION:
A minority of patients experienced significant weight loss through 5 years using lifestyle interventions alone.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Am J Gastroenterol
Year:
2024
Type:
Article
Affiliation country:
United States